Psychiatry Research
Volume 117, Issue 3 , Pages 237-243 , 25 March 2003

Unexplained transient hyperphosphatemia is more common in acute psychiatric disorders than in acute medical–surgical conditions

Received 25 January 2001 ,Revised 18 October 2002 ,Accepted 22 January 2003.

References 

  1. Bennett JC, Plum F. Cecil Text Book of Medicine. 21st ed. Philadelphia: WB Saunders Co; 1996;
  2. Carman, J.S., Wyatt, R.J., 1979a. Calcium: bivalent cation in the bivalent psychoses. Biological Psychiatry 14, 295–336
  3. Carman, J.S., Wyatt, R.J., 1979b. Calcium: pacesetting the periodic psychoses. American Journal of Psychiatry 136, 1035–1039
  4. Carman, J.S., Wyatt, R.J., 1979c. Use of calcitonin in psychotic agitation or mania. Archives of General Psychiatry 36, 72–75
  5. Dryer RL, Routh JI. Determination of serum inorganic phosphorus. Clinical Chemistry. 1963;4:191–197
  6. Fukuzako H, Fukuzako T, Kodama S, Hashiguchi T, Takigawa M, Fujimoto T. Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients. Neuropsychopharmacology. 1999;21:542–549
  7. Jabotinsky-Rubin K, Durst R, Levitan LA, Moscovich DG, Silver H, Lerner J, et al. Effects of haloperidol on human plasma magnesium. Journal of Psychiatric Research. 1993;27:155–159
  8. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Boyle DH, Verme D, et al. Behavioral compliance with dialysis prescription in hemodialysis patients. Journal of the American Society of Nephrology. 1995;5:1826–1834
  9. Snowdon JA, Macfie AC, Pearce JB. Hypocalcaemic myopathy with paranoid psychosis. Journal of Neurology, Neurosurgery and Psychiatry. 1976;39:48–52
  10. Yassa R, Nair NP, Schwartz G. Plasma magnesium in chronic schizophrenia. A preliminary report. International Pharmacopsychiatry. 1979;14:57–64

PII: S0165-1781(03)00021-0

doi: 10.1016/S0165-1781(03)00021-0

Psychiatry Research
Volume 117, Issue 3 , Pages 237-243 , 25 March 2003